Oncogen Pharma joined leading oncologists for Best of ASCO 2023, sharing landmark research updates and practical treatment insights for specialist practice in Pakistan.
An engaging DHUS session led by Dr Maryam brought together healthcare professionals to discuss contemporary oncology challenges and collaborative patient support.
Oncogen Pharma participated in ESMO Asia 2024, connecting with regional experts on advances in precision oncology, clinical evidence, and evolving standards of care.
Healthcare partners toured our Korangi Creek manufacturing facility to see GMP-led operations, quality systems, and the production standards behind Oncogen therapies.
At PSCO 2024, Oncogen Pharma engaged with Pakistan's clinical oncology community on evidence-led treatment pathways, access, and collaborative cancer care.
PSH 2024 provided a platform to connect with hematology experts, discuss evolving care needs, and highlight Oncogen's role in dependable oncology and hematology support.
The Edge Diaries captures real stories from our field teams, partners, and healthcare engagements, showing how Oncogen connects science with everyday oncology practice.
Our 2025 kick-off at 2BK Corporate aligned teams on priorities for growth, operational excellence, and delivering trusted oncology solutions across Pakistan.
Best of ASCO 2025 brought together oncology specialists to review the latest global research, emerging therapies, and practical implications for cancer care in Pakistan.
A lung cancer awareness campaign encouraged open conversation on prevention, early detection, and the importance of timely specialist care.